Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis.

Trissal MC, Wong TN, Yao JC, Ramaswamy R, Kuo I, Baty J, Sun Y, Jih G, Parikh N, Berrien-Elliott MM, Fehniger TA, Ley TJ, Maillard I, Reddy PR, Link DC.

Cancer Res. 2018 Jul 1;78(13):3510-3521. doi: 10.1158/0008-5472.CAN-17-3592. Epub 2018 May 3.

PMID:
29724719
2.

Expression profiling of snoRNAs in normal hematopoiesis and AML.

Warner WA, Spencer DH, Trissal M, White BS, Helton N, Ley TJ, Link DC.

Blood Adv. 2018 Jan 23;2(2):151-163. doi: 10.1182/bloodadvances.2017006668.

3.

Comprehensive discovery of noncoding RNAs in acute myeloid leukemia cell transcriptomes.

Zhang J, Griffith M, Miller CA, Griffith OL, Spencer DH, Walker JR, Magrini V, McGrath SD, Ly A, Helton NM, Trissal M, Link DC, Dang HX, Larson DE, Kulkarni S, Cordes MG, Fronick CC, Fulton RS, Klco JM, Mardis ER, Ley TJ, Wilson RK, Maher CA.

Exp Hematol. 2017 Nov;55:19-33. doi: 10.1016/j.exphem.2017.07.008. Epub 2017 Jul 28.

PMID:
28760689
4.

MicroRNA-223 regulates granulopoiesis but is not required for HSC maintenance in mice.

Trissal MC, DeMoya RA, Schmidt AP, Link DC.

PLoS One. 2015 Mar 20;10(3):e0119304. doi: 10.1371/journal.pone.0119304. eCollection 2015.

5.

Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon.

Ramsingh G, Jacoby MA, Shao J, De Jesus Pizzaro RE, Shen D, Trissal M, Getz AH, Ley TJ, Walter MJ, Link DC.

Blood. 2013 Oct 10;122(15):e44-51. doi: 10.1182/blood-2013-03-488007. Epub 2013 Sep 5.

6.

Complete characterization of the microRNAome in a patient with acute myeloid leukemia.

Ramsingh G, Koboldt DC, Trissal M, Chiappinelli KB, Wylie T, Koul S, Chang LW, Nagarajan R, Fehniger TA, Goodfellow P, Magrini V, Wilson RK, Ding L, Ley TJ, Mardis ER, Link DC.

Blood. 2010 Dec 9;116(24):5316-26. doi: 10.1182/blood-2010-05-285395. Epub 2010 Sep 28.

7.

Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray.

Morse DL, Balagurunathan Y, Hostetter G, Trissal M, Tafreshi NK, Burke N, Lloyd M, Enkemann S, Coppola D, Hruby VJ, Gillies RJ, Han H.

Biochem Pharmacol. 2010 Sep 1;80(5):748-54. doi: 10.1016/j.bcp.2010.05.018. Epub 2010 May 25.

8.

Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging.

Josan JS, Morse DL, Xu L, Trissal M, Baggett B, Davis P, Vagner J, Gillies RJ, Hruby VJ.

Org Lett. 2009 Jun 18;11(12):2479-82. doi: 10.1021/ol900200k.

9.

Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer.

Balagurunathan Y, Morse DL, Hostetter G, Shanmugam V, Stafford P, Shack S, Pearson J, Trissal M, Demeure MJ, Von Hoff DD, Hruby VJ, Gillies RJ, Han H.

Mol Cancer Ther. 2008 Sep;7(9):3071-80. doi: 10.1158/1535-7163.MCT-08-0402. Epub 2008 Sep 2.

Supplemental Content

Loading ...
Support Center